(Total Views: 660)
Posted On: 09/08/2020 11:17:17 AM
Post# of 145873
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Crujones1985 #54650
Was it a double-blind clinical trial? If not, then it is 'anecdotal' by the EFF-DA's standard applied to leronlimab. How did leronlimab perform 'anecdotally'? Much better than 30% with the absolute worst of the worst with multiple comorbidities....is what I recall. So yeah, what were you saying?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)